These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 11167765

  • 1. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.
    Martinelli I, Bucciarelli P, Margaglione M, De Stefano V, Castaman G, Mannucci PM.
    Br J Haematol; 2000 Dec; 111(4):1223-9. PubMed ID: 11167765
    [Abstract] [Full Text] [Related]

  • 2. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G.
    N Engl J Med; 1999 Sep 09; 341(11):801-6. PubMed ID: 10477778
    [Abstract] [Full Text] [Related]

  • 3. Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis.
    Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, Prins MH, Büller HR, van der Meer J.
    Blood Coagul Fibrinolysis; 2001 Dec 09; 12(8):713-20. PubMed ID: 11734673
    [Abstract] [Full Text] [Related]

  • 4. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, Sandmann W, Zotz RB.
    N Engl J Med; 2000 Feb 10; 342(6):374-80. PubMed ID: 10666427
    [Abstract] [Full Text] [Related]

  • 5. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM, Middeldorp S, Veeger NJ, Hamulyák K, Prins MH, Büller HR, van der Meer J.
    Circulation; 2010 Apr 20; 121(15):1706-12. PubMed ID: 20368522
    [Abstract] [Full Text] [Related]

  • 6. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
    Tzoran I, Papadakis M, Brenner B, Fidalgo Á, Rivas A, Wells PS, Gavín O, Adarraga MD, Moustafa F, Monreal M, Registro Informatizado de Enfermedad TromboEmbólica Investigators.
    Am J Med; 2017 Apr 20; 130(4):482.e1-482.e9. PubMed ID: 27986523
    [Abstract] [Full Text] [Related]

  • 7. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
    Marchiori A, Mosena L, Prins MH, Prandoni P.
    Haematologica; 2007 Aug 20; 92(8):1107-14. PubMed ID: 17650440
    [Abstract] [Full Text] [Related]

  • 8. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J.
    Haematologica; 2008 May 20; 93(5):729-34. PubMed ID: 18387978
    [Abstract] [Full Text] [Related]

  • 9. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F.
    Haematologica; 2000 Dec 20; 85(12):1271-6. PubMed ID: 11114134
    [Abstract] [Full Text] [Related]

  • 10. The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A.
    Martinelli I, Battaglioli T, De Stefano V, Tormene D, Valdrè L, Grandone E, Tosetto A, Mannucci PM, GIT (Gruppo Italiano Trombofilia).
    J Thromb Haemost; 2008 Mar 20; 6(3):494-8. PubMed ID: 18182035
    [Abstract] [Full Text] [Related]

  • 11. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I, Legnani C, Bucciarelli P, Grandone E, De Stefano V, Mannucci PM.
    Thromb Haemost; 2001 Sep 20; 86(3):800-3. PubMed ID: 11583310
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.
    Coen D, Zadro R, Honović L, Banfić L, Stavljenić Rukavina A.
    Croat Med J; 2001 Aug 20; 42(4):488-92. PubMed ID: 11471205
    [Abstract] [Full Text] [Related]

  • 13. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL.
    Thromb Haemost; 2001 Sep 20; 86(3):809-16. PubMed ID: 11583312
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease.
    De Stefano V, Zappacosta B, Persichilli S, Rossi E, Casorelli I, Paciaroni K, Chiusolo P, Leone AM, Giardina B, Leone G.
    Br J Haematol; 1999 Aug 20; 106(2):564-8. PubMed ID: 10460623
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of factor V Leiden and prothrombin 20210 A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosis.
    Boyanovsky B, Russeva M, Ganev V, Penev M, Baleva M.
    Blood Coagul Fibrinolysis; 2001 Dec 20; 12(8):639-42. PubMed ID: 11734663
    [Abstract] [Full Text] [Related]

  • 16. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR, García-Sanz R, Alberca I, López ML, Balanzategui A, Gutierrez O, Lozano F, San Miguel J.
    Blood Coagul Fibrinolysis; 2006 Jan 20; 17(1):23-8. PubMed ID: 16607075
    [Abstract] [Full Text] [Related]

  • 17. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M, Mitic G, Mikovic Z, Antonijevic N, Djordjevic V, Mikovic D, Mandic V, Rakicevic L, Radojkovic D.
    Clin Appl Thromb Hemost; 2010 Feb 20; 16(1):66-70. PubMed ID: 18796457
    [Abstract] [Full Text] [Related]

  • 18. Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?
    Méan M, Limacher A, Stalder O, Angelillo-Scherrer A, Alberio L, Fontana P, Beer HJ, Rodondi N, Lämmle B, Aujesky D.
    Am J Med; 2017 Oct 20; 130(10):1220.e17-1220.e22. PubMed ID: 28606797
    [Abstract] [Full Text] [Related]

  • 19. High prevalence of factor V Leiden and prothrombin G20101A mutations in Kashmiri patients with venous thromboembolism.
    Shafia S, Zargar MH, Khan N, Ahmad R, Shah ZA, Asimi R.
    Gene; 2018 May 15; 654():1-9. PubMed ID: 29454086
    [Abstract] [Full Text] [Related]

  • 20. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.
    Martinelli I, Battaglioli T, Razzari C, Mannucci PM.
    J Thromb Haemost; 2007 Jan 15; 5(1):98-101. PubMed ID: 17067362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.